Tissue inhibitor of metalloproteinase-1 is an early marker of acute endothelial dysfunction in a rodent model of venous oxidative injury.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Annals of Vascular Surgery

• Publication date

  2009-07-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.avsg.2009.03.005PMID 19467832
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Nebivolol on Endothelial Gene Expression during Oxidative Stress in Human Umbilical Vein Endothelial Cells

  2008cited by this paper
• A Comparison of Arteries and Veins in Oxidative Stress: Producers, Destroyers, Function, and Disease

  2007cited by this paper
• Endothelial injury in the initiation and progression of vascular disorders.

  2007cited by this paper
• Adaptation of a photochemical method to initiate recurrent platelet-mediated thrombosis in small animals

  2007cited by this paper
• Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis.

  2006cited by this paper
• Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2.

  2005cited by this paper
• The rat ear vein model for investigating in vivo thrombogenicity of ultrafine particles (UFP).

  2005cited by this paper
• Decreased venous thrombosis with an oral inhibitor of P selectin.

  2005cited by this paper
• Redox Mechanisms of Cytoprotection by Bcl-2

  2005cited by this paper
• The Role of Endothelial Cells in the Resolution of Acute Inflammation

  2005cited by this paper
• Tissue Inhibitor of Metalloproteinase 1 Adenoviral Gene Therapy Alone Is Equally Effective in Reducing Restenosis as Combination Gene Therapy in a Rabbit Restenosis Model

  2005cited by this paper
• Matrix metalloproteinases and free radicals in cerebral ischemia.

  2005cited by this paper
• Observation of arterial and venous thrombus formation by scanning and transmission electron microscopy

  2004cited by this paper
• Tissue inhibitors of metalloproteases: Regulation and biological activities

  2004cited by this paper
• Acute coronary disease Athero-Inflammation: Therapeutic approach

  2003cited by this paper
• Metalloproteinases in Development and Progression of Vascular Disease

  2003cited by this paper
• P-selectin and leukocyte microparticles are associated with venous thrombogenesis.

  2003cited by this paper
• Endothelial Dysfunction: A Marker of Atherosclerotic Risk

  2003cited by this paper
• Risk factors in coronary atherosclerosis athero-inflammation: the meeting point

  2003cited by this paper
• Peptide-retargeted adenovirus encoding a tissue inhibitor of metalloproteinase-1 decreases restenosis after intravascular gene transfer.

  2002cited by this paper
• Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis.

  2002cited by this paper
• Systemic tissue inhibitor of metalloproteinase‐1 gene delivery reduces neointimal hyperplasia in balloon‐injured rat carotid artery

  2002cited by this paper
• Endothelial Regulation of Vasomotion in ApoE-Deficient Mice: Implications for Interactions Between Peroxynitrite and Tetrahydrobiopterin

  2001cited by this paper
• Laser-induced noninvasive vascular injury models in mice generate platelet- and coagulation-dependent thrombi.

  2001cited by this paper
• Modulation of Protein Kinase Activity and Gene Expression by Reactive Oxygen Species and Their Role in Vascular Physiology and Pathophysiology

  2000cited by this paper
• Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress.

  2000cited by this paper
• Hyperlipidemia promotes thrombosis after injury to atherosclerotic vessels in apolipoprotein E-deficient mice.

  2000cited by this paper
• Endothelial apoptosis: could it have a role in the pathogenesis and treatment of disease?

  2000cited by this paper
• Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery.

  2000cited by this paper
• Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation

  2000cited by this paper
• Tissue inhibitors of metalloproteinases: evolution, structure and function.

  2000cited by this paper
• Tissue inhibitor of matrix metalloproteinases-1 impairs arterial neointima formation after vascular injury in mice.

  1999cited by this paper
• Oxidative stress as a regulator of gene expression in the vasculature.

  1999cited by this paper
• Matrix Metalloproteinases*

  1999cited by this paper
• Matrix metalloproteinases: structures, evolution, and diversification

  1998cited by this paper
• Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model.

  1998cited by this paper
• Bacterial Lipopolysaccharide Disrupts Endothelial Monolayer Integrity and Survival Signaling Events through Caspase Cleavage of Adherens Junction Proteins*

  1998cited by this paper
• BCL-2 family: regulators of cell death.

  1998cited by this paper
• Elastin Degradation by Matrix Metalloproteinases

  1997cited by this paper
• Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.

  1997cited by this paper
• Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes.

  1996cited by this paper
• Vascular endothelium: an integrator of pathophysiologic stimuli in atherosclerosis.

  1995cited by this paper
• Vessel Wall Injury and Arterial Thrombosis Induced by a Photochemical Reaction

  1995cited by this paper
• Matrix metalloproteinases and cardiovascular disease.

  1995cited by this paper
• Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP).

  1991cited by this paper
• This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba

  year unknowncited by this paper

• Tissue Inhibitor of Matrix Metalloproteinases-1 (TIMP-1) and Pulmonary Involvement in COVID-19 Pneumonia

  2023cites this paper
• Cardiovascular Research

  2020cites this paper
• Human decidua basalis mesenchymal stem/stromal cells protect endothelial cell functions from oxidative stress induced by hydrogen peroxide and monocytes

  2018cites this paper
• Expression Profiling of Genes Related to Endothelial Cells Biology in Patients with Type 2 Diabetes and Patients with Prediabetes

  2016cites this paper
• Effect of elastin-derived peptides on the production of tissue inhibitor of metalloproteinase-1, -2, and -3 and the ratios in various endothelial cell lines.

  2015cites this paper
• Serum MMP-8 and TIMP-1 in Critically Ill Patients with Acute Respiratory Failure: TIMP-1 Is Associated with Increased 90-Day Mortality

  2014cites this paper
• Matrix metalloproteinases in critically ill patients

  2013cites this paper
• Recent Insights into the Molecular and Cellular Contributions to Venous Thrombosis

  2012cites this paper
• Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection

  2010cites this paper
• Thrombogenesis with continuous blood flow in the inferior vena cava

  2010cites this paper
• Clear cell carcinoma of the ovary: potential pathogenic mechanisms (Review).

  2010cites this paper